Hypertension and Cognitive Function in the Elderly

Disease-a-Month

Volumn 56, Issue 3, 2010, Pages 106-147

  Cherubini, Antonio ^a   Lowenthal, David T ^b   Paran, Esther ^c   Mecocci, Patrizia ^d   Williams, Leonard S ^d   Senin, Umberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF FLORIDA   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; HYPNOTIC SEDATIVE AGENT; METHYLDOPA; NEUROLEPTIC AGENT; PERINDOPRIL; PLACEBO; PROPRANOLOL; RESERPINE;

AGING; ALZHEIMER DISEASE; APHASIA; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CHRONIC LIVER DISEASE; CLINICAL TRIAL; COGNITION; CONSCIOUSNESS; DECISION MAKING; DELIRIUM; DEMENTIA; DEMYELINATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EARLY DIAGNOSIS; ELDERLY CARE; GLYCEMIC CONTROL; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPONATREMIA; MEMORY; MENTAL DETERIORATION; MICROANGIOPATHY; MORBIDITY; MORTALITY; MOTOR CONTROL; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PSYCHOSIS; QUALITY OF LIFE; REACTION TIME; REVIEW; RISK FACTOR; SENSORIMOTOR FUNCTION; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; UREMIA; WHITE MATTER;

AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COGNITION; COGNITION DISORDERS; HUMANS; HYPERTENSION; LEUKOARAIOSIS;

EID: 77249145449     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.12.007     Document Type: Review

References (178)

1. Lowenthal D.T., Powers S., Pollock M.L., et al. Interactions of Blockage and Exercise: Implications and Applications for the Elderly. Am J Geriatr Cardiol 1 (1992) 42-57
2. Vogt T.M., Ireland C.C., Black D., et al. Recruitment of elderly volunteer for multi-center clinical trial: The SHEP pilot study. Controlled Clin Trials 7 (1986) 118
3. Kannel W.B., and Gordon T. Evaluation of cardiovascular risk in the elderly: The Framingham study. Bull NY Acad Med 54 (1978) 573
4. O'Connor D.W., Pollitt P.A., Ilyde J.B., et al. The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 79 (1989) 190-198
5. Ueda K., Kawano H., Hasuo Y., et al. Prevalence and etiology of dementia in a Japanese community. Stroke 23 (1992) 798-802
6. Zhang M., Katzman R., Salmon D., et al. The prevalence of dementia and Alzheimer's disease in Shangai, China: impact of age, gender, and education. Ann Neurol 27 (1990) 428-437
7. Rocca W.A., Bonaiuto S., Lippi A., et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door to door study in Appingnano, Macerata Province, Italy. Neurology 40 (1990) 626-631
8. Barclay L.L. Survival in Alzheimer's disease and vascular dementias. Neurology 35 (1985) 834
9. Molsa P.K., Martilla R.J., and Rinne U.K. Survival and cause of death in Alzheimer's disease and vascular dementia. Acta Neurol Scand 74 (1986) 103-107
10. Skoog I., Nilsson L., Palmertz B., et al. A population based study of dementia in 85-years olds. N Engl J Med (1993) 153-158
11. Yoshitake T., Kiyohara Y., Kato I., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 45 (1995) 1161-1168
12. Lindsay J., Ilébert R., and Rockwood K. The Canadian Study of Health and Aging: Risk factors for vascular dementia. Stroke 48 (1997) 526-530
13. Skoog I. Risk factors for vascular dementia. Dementia 5 (1994) 137
14. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 17 (1998) 2-9
15. Saunders A.M., Strillmatter W.J., and Schmechel D. Association of Apolipoprotein E 4 allele with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
16. Frisoni G.B., Calabresi L., Geroldi C., et al. Apolipoprotein E 4 allele in Alzheimer's disease and vascular dementia. Dementia 5 (1994) 240-242
17. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 53 (1976) 720-727
18. Strandgaard S., and Paulson O.B. Cerebrovascular consequences of hypertension. Lancet 344 (1994) 519-524
19. Goodwin J.S. Embracing Complexity: A consideration of hypertension in the very old. J Gerontol A Biol Sci Med Sci 58 (2003) 653-658
20. Lowenthal D.T. Commentary on "Embracing complexity: A Consideration of Hypertension in the Very Old". J Gerontol A Biol Sci Med Sci 58 (2003) 664-665 discussion 669-70
21. Vincent K.R., Vincent H.K., Braith R.W., et al. Strength Training and Hemodynamic Responses to Exercise. Lowenthal, Am J Geriatr Cardiol 12 (2003) 97-106
22. Larson E.B., Kukull W.A., Buchner D., et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107 (1987) 169-173
23. Prince M.J. The treatment of hypertension is in older people and its effect on cognitive function. Biomed Pharmacother 51 (1997) 208-212
24. Liao D., Cooper L., Cai J., et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control. Stroke 27 (1996) 2262-2270
25. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
26. The PROGRESS Collaborative Group. Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients with Cerebrovasular Disease. Arch Intern Med 163 (2003) 1069-1075
27. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomized double-blind placebo controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
28. Elias M.F., Wolf P.A., D'Agostino R.B., et al. Untreated blood pressure level is inversely related to cognitive functioning. The Framingham Study. Am J Epidemiol 138 (1993) 353-364
29. Waldstein S.R., Manuck S.B., Ryan C.M., et al. Neuropsychological correlates of hypertension: review and methodological considerations. Psychol Bull 110 (1991) 451-468
30. Frisoni G.B., Calabresi L., Geroldi C., et al. Apolipoprotein E_4 allele in Alzheimer's disease and vascular dementia. Dementia 5 (1994) 240-242
31. Applegate W.B., Pressel S., Wittes J., et al. Impact in the treatment of isolated systolic hypertension of behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 154 (1994) 2154-2160
32. Soloman S., Hotchkiss E., Saravay S.M., et al. Impairment of memory function by antihypertensive medication. Arch Gen Psychiatry 40 (1983) 1109-1112
33. van Swieten J.C., Geyskes G.G., Derrix M.M.A., et al. Hypertension in the elderly is associated with white matter lesions and congitive decline. Ann Neurol 30 (1991) 825-830
34. Burke D.M., and Harrold R.M. Automatic effortful semantic processes in old age: experimental and naturalistic approaches. In: Light L.L., and Burke D.M. (Eds). Language, Memory and Aging (1988), Cambridge University Press, New York 100-116
35. Glynn R.J., Beckett L.A., Hebert L.E., et al. Current and remote blood pressure and cognitive decline. JAMA 281 (1999) 438-445
36. Dimsdale J.E., Newton R.P., and Joist T. Neuropsychological side effects of ß-blockers. Arch Intern Med 149 (1989) 514-525
37. Elias M.F., Robbins M.A., Shultz N.R., et al. Clinical significance of cognitive performance by hypertensive patients. Hypertension 9 (1987) 192-197
38. Lindsay J., Hébert R., and Rockwood K. The Canadian Study of Health and Aging: Risk factors for vascular dementia. Stroke 48 (1997) 526-530
39. Applegate W.B., Phillips H.L., Schnaper H., et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 151 (1991) 1817-1823
40. Taylor J.O., Cornioni-Huntley J., Curb J.D., et al. Blood pressure and mortality risk in the elderly. Am J Epidemiol 134 (1991) 489
41. Scherr P.A., Hebert L.E., Smith L.A., et al. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol 134 (1991) 1303-1315
42. Wallace R., Blemke J.H., Morris M.C., et al. Relationship of free recall memory to hypertension in the elderly. The Iowa 65+ rural health study. J Chron Dis 38 (1985) 475-481
43. Pantoni L., Garcia J.H., and Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 27 (1996) 1641-1647
44. Schlotterer G., Moscovitch M., Crapper M., et al. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal aging and Alzheimer's disease. Brain 107 (1984) 309-325
45. Vaitkevicius P.V., Fleg J.L., Engl J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 88 (1993) 1456-1462
46. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis. Hypertension 25 (1995) 155-161
47. Cruikshank J.M., Thorp J.M., and Zacharis F.J. Benefits and potential harm of lowering high blood pressure. Lancet i (1987) 581-584
48. Roman G.C., Tatemichi T.K., Erkinijutti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSD-AIREN International Workshop. Neurology 43 (1993) 250-260
49. Fletcher A.E., and Bulpitt C.J. How far should blood pressure be lowered?. N Eng J Med 326 (1992) 251-254
50. Zwetnow N.N. Pathophysiology of autoregulation. In: Minderhoud J.M. (Ed). Cerebral Blood Flow: Basic Knowledge and Clinical Implications (1981), Excerpta Medica, Amsterdam
51. Zhang M., Katzman R., Salmon D., et al. The prevalence of dementia and Alzheimer's disease in Shangai, China: impact of age, gender, and education. Ann Neurol 27 (1990) 428-437
52. Kwok RPS, Juorio AW. Facilitating effect of insulin on brain 5-hydroxytriptamine metabolism. Neuroendocrinology 197;45:267-73.
53. Canestrari R.E. The effects of commonality on paired-associated learning in two age groups. J Genetic Psychol 108 (1996) 3-7
54. Hardy J., Adolfsen R., Alafuzoff I., et al. Transmitter deficits in Alzheimer's disease. Neurochem Int 7 (1985) 545-563
55. Hong Y.L. The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. Int J Clin Pharmacol Ther Toxicol 11 (1987) 589-597
56. Starr J.M., Whalley I.J., and Deary I.J. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 44 (1996) 411-415
57. Overgaard J.M. Cerebral blood flow and severe head injury. In: Minderhoud J.M. (Ed). Cerebral Blood Flow: Basic Knowledge and Clinical Implications (1981), Excerpta Medica, Amsterdam
58. Skoog I. The relationship between blood pressure and dementia: a review. Biomed & Pharmacother 51 (1997) 367-375
59. Erkinjuntti T., Ketonen L., Sulkava R., et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?. J Neurol Neurosurg Psychiatry 50 (1987) 37-42
60. Erkinjuntti T., Ostbye T., Steenhuis R., et al. The effects of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337 (1997) 1667-1674
61. Skoog I., Nilsso L., Palmertz B., et al. A population based study of dementia in 85-year-olds. N Eng J Med 328 (1993) 153-158
62. Blum J.E., Javich L.F., and Clark E.T. Rate of change on selective tests of intelligence: a twenty-five longitudinal study of aging. J Gerontol 25 (1970) 171-176
63. Rocca W.A., Bonaiuto S., Lippi A., et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door to door study in Appignano, Maccerata Province, Italy. Neurology 40 (1990) 626-631
64. Roman G.C., Tatemichi T.K., Erkinijutti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSD-AIREN International Workshop. Neurology 43 (1993) 250-260
65. Celesia G.C., and Daly R.F. Effects of aging on visual evoked responses. Arch Neurol 34 (1977) 403-407
66. Alberts M.J., Graffagnino C., McClenny C., et al. ApoE genotype and survival from intracerebral hemorrhage. Lancet 346 (1995) 575 (letter)
67. Applegate W.B., Pressel S., Eittes J., et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med 154 (1994) 2154-2160
68. Maxwell C.J., Hogan D.B., and Ebly E.M. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 161 (1991) 501-506
69. Seux M.I., Thijs L., Forette F., et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 16 (1998) 963-969
70. Zhu L., Viitanen M., Guo Z., et al. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three year follow-up. J Clin Epidemiol 51 (1998) 385-391
71. Birns J., and Kalra L. Blood pressure and vascular cognitive impairment: the debate continues. J Hum Hypertens 20 (2006) 1-3
72. Launer L.J., Masaki K., Petroviecb H., et al. The association between mid-life blood pressure levels and late-life cognitive function: The Honolulu-Asia aging study. JAMA 274 (1995) 1846-1851
73. Feigin V., Ratnasabapathy Y., and Andersn C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?. J Neurol Sci 229 -230 (2005) 151-155
74. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). SHEP Cooperative Research Group. JAMA 265 (1991) 3255-3264
75. Prince M.J., Bird A.S., Blizard R.A., et al. Is the cognitive function of older patients affected by antihypertensive treatment?. Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 312 (1996) 801-805
76. Lithell H., Hansson L., Skoog I., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens 22 (2004) 1605-1612
77. Forette I., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomized, double-blind, placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
78. Feldmann E. Intracerebral hemorrhage. Stroke 22 (1991) 684-491
79. Starr J.M., Whalley L.J., and Deary I.J. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 44 (1996) 411-415
80. Starr J.M., and Whalley L.J. Differential cognitive outcomes in the hypertensive old people in Edinburgh study. J Neurol Sci 229 -230 (2005) 103-107
81. Alagiakrishnan K., McCracken P., and Feldman H. Treatment vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline?. Postgrad Med J 82 (2006) 101-105
82. Guo Z., Vitanen M., Fratiglioni L., et al. Low blood pressure and dementia in elderly people: the Kungshol-men project. Br Med J 312 (1996) 805-808
83. Lindgren A., Roijer A., Rudling O., et al. Cerebral lesion on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke 25 (1994) 929-934
84. Brust J.C. Antihypertensive therapy and cognition: more questions than answers. Stroke 37 (2006) 1146
85. Faston J.D., Albers G.W., Caplan L.R., et al. Discussion: reconsideration of TIA terminology and definitions. Neurology 62 (2004) 529-534
86. Phillips S.J., and Whisnant J.P. Hypertension and stroke. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension: pathophysiology, diagnosis and management (1990), Raven Press, New York, NY 417-431
87. Strandgaard S., and Paulson O.B. Cerebrovascular consequence of hypertension. Lancet 344 (1994) 519-524
88. Granick S. Psychological test functioning. In: Granick S., and Patterson R.D. (Eds). Human Aging II: US Department of Health, Education and Iluman Welfare (1971), DHEW Publication (HSM), Rockville, MD 70-90
89. Sparks D.L., Scheff S.W., Liu H., et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 131 (1995) 162-168
90. Waldstein S.R., Ryan C.M., Manuck S.B., et al. Learning and memory function in men with untreated blood pressure elevation. J Consult Clin Psychol 79 (1991) 513-517
91. Fukuda H., and Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 26 (1995) 1593-1597
92. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 150 (1994) 899-913
93. Barbeger-Gateau P., and Fabrigaule C. Disability and Cognitive Impairment in the Elderly. Disabil Rehabil 19 (1997) 175-193
94. Stoog I., Nilsso L., Palmertz B., et al. A population based study of demential in 85-year-olds. N Eng J Med 328 (1993) 153-158
95. Kinkel W.R., Jacobs L., Palochini I., et al. Subcortical arteriosclerotic encephalopathy (Binswanger's disease): computed tomography, nuclear magnetic resonance and clinical correlations. Arch Neurol 52 (1985) 659-664
96. Feldmann E. Intracerebral hemorrhage. Stroke 22 684 (1991) 491
97. Senin U. The aging brain (1983), Editriec Sigla Trc, Perugia
98. Senin U., Parnetti I., and Mecocci P. The aging demented brain and calcium antagonists (1994), Intramed communications
99. Senin U., Aisa G., Catani M., et al. Aging patient and geriatric fundamentals of geronotology and geriatrics (1999), EdiScs
100. Skinner H., Futerman A., Morrissette D., et al. Atenolol compared with infedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med 116 (1992) 615-623
101. Suzman R.M., Willis D.P., and Manton K.G. The oldest old (1992), Oxford University press
102. Ingvar D.H., and Lassen N.A. Regulation of cerebral blood flow. In: Himwich H.E. (Ed). Brain Metabolism and Cerebral Disorders. 2nd Ed. (1976), Spectrum Publications, New York 181 Ch 8
103. van Boxtel M.P., Gaillard C., Houx P.J., et al. Can the blood pressure predict cognitive task performance in a healthy population sample?. J Hypertens 15 (1997) 1069-1076
104. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for endpoint reduction in hypertension study (LIFT): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
105. Paran E., Horaf R.A., Hanson A., et al. Blood pressure and cognitive functioning among independent elderly. Am J Hypertens 16 (2003) 818-826
106. PROGRESS Collaborative Group. Randomised trial of a perindepril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
107. Brun A., Englund B., and Gustafason L. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiat 57 (1994) 417-418
108. Meyer J.S. Improved method for non-invasive measurement of regional cerebral blood flow by 133 Xenon inhalation, Part II: measurements in health and disease. Stroke 9 (1978) 205
109. Acherio A., Hennekens C., Willett C., et al. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27 (1996) 1065-1072
110. Kral V.A. Senescent forgetfulness: benign or malignant. Can Med Assoc J 86 (1962) 257-260
111. Krakof L.R. Renal and adrenal mechanism pertinent to hypertension in an aging population. In: Horan M.J., Steinberg G.M., Dunbar J.A.B., et al. (Eds). Blood Pressure Regulation and Aging (1986), Biomedical Information Corp, New York
112. Zijlstra W.G. Physiology of the cerebral circulation. In: Minderhoud J.M. (Ed). Cerebral Blood Flow: Basic Knowledge and Clinical Implications (1981), Excerpta Medica, Amsterdam
113. Mrak R.E., Griffin W.S.T., and Graham D.L. Aging-associated changes in human brain. J Neuropathol Exp Neurol 56 (1997) 1269-1275
114. Crook T., Bartus R.T., Ferris S.H., et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group. Dev Neuropsychol 4 (1986) 261-276
115. Bierman E.I. Aging and atherosclerosis. In: Hazzard W.R., Bierman E.L., Blass J.P., et al. (Eds). Principles of Geriatric Medicine and Gerontology. 3rd Ed. (1994), McGraw-Hill, New York
116. Hendrie H.C. Epidemiology of Dementia and Alzheimer's Disease. Am J Geriatr Psychiatry 6 2 Suppl 1 (1998) S3-S18
117. Applegate W.B., Pressel S., Wittes J., et al. Impact in the treatment of isolated systolic hypertension in the elderly program. Arch Intern Med 154 (1994) 2154-2160
118. Craik F.I.M. Two components in free recall. J Verbal Learn Verbar Behav 7 (1968) 996-1004
119. Birren J.E., and Fisher M. Aging and speed of behavior: possible consequences for psychological functioning. Ann Rev Psychol 46 (1995) 329-353
120. Hazzard W.R. The scx differential in longevity. In: Hazzard W.R., Bierman E.L., Blass J.P., et al. (Eds). Principles of Geriatric Medicine and Gerontology. 3rd Ed. (1994), McGraw-Hill, New York 37-47
121. Krakof L.R. Renal and adrenal mechanism pertinent to hypertension in an aging population. In: Horan M.J., Steinberg G.M., Dunber J.A.B., et al. (Eds). Blood Pressure Regulation and Aging (1986), Biomedical Information Corp, New York
122. Gill T.M., Richardson F.T., and Tinetti M.E. Evaluating the risk of dependence in activities of daily living among community living older adults with mild to moderate cognitive impairment. J Gerontol 5 (1995) M235-M241
123. Chobanian A.V. Pathophysiologic considerations in the treatment of the elderly hypertension patient. Am J Cardiol 52 (1983) 49D
124. Abrass I.B. Vatecholamine levels and vascular responsiveness in aging. In: Horan M.J., Steinberg G.M., Dunber J.B., et al. (Eds). Blood Pressure Regulation and Aging (1986), Biomedical Information Corp, New York
125. Folstein M., Folstein S., and McHugh P. Mini Mental State: a practical method for grading the cognitive state of patients for a clinician. J Psychiatr Res 12 (1975) 189-198
126. Forette F., Scux M.L., Staessen J.A., et al. Prevention of dementia in randomized double-blind placebo controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
127. Lipowsky Z.J. Delirum: Acute confusinal States (1990), Oxford University Press, New York
128. Craik F.I.M. Short-term memory and the aging process. In: Talland G.A. (Ed). Human Aging and Behavior (1968), Academic Press, New York 131-168
129. Stuart-Hamilton I. The psychology of aging, an introduction (1991), Jessica Kingsley Publisher, London
130. Burke W.J., Coronado P.G., Schmitt C.A., et al. Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst 48 (1994) 65-71
131. Skoog I. Risk Factors for vascular dementia. Dementia 5 (1994) 137
132. Wilkie F., and Eisdorfer C. Intelligence and blood pressure in the aged. Science 172 (1971) 959-962
133. Cattel R.B. Abilities: their structure, growth and action (1971), Houghton-Mifflin, Boston
134. Strandgaard S., and Paulson O.B. Cerebrovascular consequences of hypertension. Lancet 344 (1994) 519-524
135. Chimovitz M.I., Awad I.A., and Furlan A.J. Periventricular lesions on MRI. Facts and theories. Stroke 20 (1989) 963-967
136. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke and coronary heart disease, Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
137. Erkinjuntti T., Gao F., Lee D.H., et al. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 51 (1994) 1084-1089
138. Linee guida 1999 per il trattamento dell'organizzazione mondiale della Sanita' (OMS) c della Secieta' Internazio-nale dell'Ipertensione (ISH). J Hypertens 17 (1999) 151-183
139. Skoog I., Lernfelt B., Landahal S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
140. Hatazawa J., Yamaguchi T., Ito M., et al. Association of hypertension with increased atrophy of brain matter in the elderly. J Am Geriatr Soc 32 (1984) 370-371
141. Campion E.W. The oldest old. N Engl J Med 330 (1994) 1819-1820
142. Ileckbert S.R., Longsteth W.T., Psaty B.M., et al. The association of antihypertensive examination in older adults. J Am Geriatr Soc 45 (1997) 1423-1433
143. Schwartz M., Creascy H., Grady C.L., et al. Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21 to 81 years. Ann Neurol 17 (1985) 146-157
144. Aronson M.K., Post D.C., Guastadisegni P., et al. Weight changes and dementia. In: Corain B., lqbal K., Nicolini M., et al. (Eds). Alzheimer's Disease: Advances in Clinical and Basic Research (1993), Jolut Wiley and Sons, New York 55-63
145. Wylie C.M. Contrast in the health of elderly men and women: an analysis of recent data for Whites in the United States. J Am Geriatr Soc 38 (1984) 670-675
146. Salcrno J.A., Murphy D.G.M., Horwitz B., et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 20 (1992) 340-348
147. Albert M., Smith L.A., Scherr P.A., et al. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 31 (1991) 167-178
148. Moody D.L., Bell M.A., and Challa V.R. Regional cerebral vulnerability to perfusion deficits in the elderly. New Issues Neurosci 4 (1992) 133-145
149. Launer L.J., Anersen K., Dewey M.E., et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. FURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52 (1999) 78-84
150. Skoog I., Nilsso L., Palmertz B., et al. A population based study of dementia in 85-year-olds. N Eng J Med 328 (1993) 153-158
151. Havlik R.J. Antihypertensive drugs, brain structure and cognitive function: more research is necessary. J Am Geriatr Soc 45 (1997) 1529-1531
152. Cohen M.L., and Berkowitz B.A. Vascular contraction: effective age and extracellular calcium. Res Commun Chem Pathol Pharmacol 26 (1979) 433
153. Langer D.R., Ganiats T.G., and Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. Br Med J 298 (1989) 1356-1358
154. Meyer J.S., Judd B.W., Tawaklna T., et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 256 (1986) 2203-2209
155. Roman G.C. From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research. Stroke 27 (1996) 1269-1273
156. Mann S.J. Systolic hypertension in the elderly. Arch Intern Med 152 (1992) 1977-1984
157. Bryan P., Efong D.O., Steward-Jones J., et al. Propranolol on tests of visual function and central nervous system activity. Br J Clin Pharmacol 1 (1974) 82-84
158. Roman G.C. Form UBOs to Binswanger's discase. Impact of magnetic resonance imaging on vascular dementia research. Stroke 27 (1996) 1269-1273
159. Pantoni I., and Garcia J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger' disease. Stroke 26 (1995) 1293-1301
160. Awad I.A., Spetzler R.F., Hodak J.A., et al. Incidental subcortical lesion identified on magnetic resonance imaging in the elderly. I: correlation with the age and cerebrovascular risk factors. Stroke 17 (1986) 1084-1089
161. Lopez O.L., Beeker J.T., Jungreis C.A., et al. Computed tomography, but not magnetic resonance imaging-identified periventricular white matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 52 (1995) 659-664
162. Farmer M.E., Withe L.R., Abbot R.D., et al. Blood pressure and cognitive performance: The Framingham study. Am J Epidemiol 126 (1987) 1103-1114
163. Bryan P., Efong D.O., Steward-Jones J., et al. Propranolol on tests of visual function and central nervous system activity. Br J Clin Pharmacol 1 (1974) 82-84
164. Schmidt R., Fazekas F., Koch M., et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects: a case-control study. Arch Neurol 52 (1995) 856-910
165. Longstreth W.T., Manolio T.A., Arnold A., et al., cardiovascular health study group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 (1996) 1274-1282
166. Hallock P., and Benson I.C. Studies of the elastic properties of human isolated aorta. J Clin Invest 16 (1937) 595
167. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. (1994), American Psychiatric Association, Washington, DE
168. Sixth report of the Joint National Committee on Prevention, Detection. Evaluation and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2445
169. Roman G.C. From UBOs to Binxwanger's disease. Impact of magnetic resonance imaging on vascular dementia research. Stroke 27 (1996) 1269-1273
170. Salvioli G., Mussi C., and Ascari S. Il Deliruim nell' Anziano. Giorn Geront 46 (1998) 423-432
171. Kuusisto J., Koivisto K., Mykkanen L., et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 22 (1993) 771-779
172. Phillips S.J., and Whisnant J.P. Hypertension and stroke. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension, Pathophysiology, Diagnosis and Management (1990), Raven Press, New York 417-31
173. Gist Y.J., and Velkoff V.A. Gender and aging. Demographic dimensions. International brief. Bureau of Census (1997), US Department of Commerce, Economics and Statistics Administration
174. Lopez O.L., Becker J.T., Jungreis C.A., et al. Computed tomography, but not magnetic resonance imaging identified periventricular white matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 52 (1995) 659-664
175. Hypertension DetectionFollow-up Program Co-operative Group: Blood pressure studies in 14 communities. JAMA 237 (1977) 2385
176. Hughes C.P., Berg L.D.Wl., et al. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
177. Ruitenberg A., van Sweiten J.C., Wittemen J.C.M., et al. Alcohol consumption and risk of demential: the Rotterdam Study. Lancet 259 (2002) 281-58
178. Black S., Roman G.C., Geldmacher D.S., et al., Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of doneprezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trail. Stroke 34 (2003) 2323-2330